Menotrope [HMG – 225IU] – 3 Vials – Corey Pauling

Laboratory: Corey Pauling
Form: Subcutaneous injection
Molecule: Human Menopausal Gonadotropin (HMG)
Concentration: 75 IU/vial
Volume: 3 vials
Menotrope [75 IU] contains Human Menopausal Gonadotropin (HMG), providing both FSH and LH activity. It primarily supports spermatogenesis, testicular function, and male fertility. For bodybuilding practitioners, HMG is particularly relevant in situations involving HPG-axis suppression, especially when maintaining or restoring testicular and reproductive function is a priority.

Description and Effects

MENOTROPE [HMG 75 IU] contains Human Menopausal Gonadotropin (HMG), a gonadotropin preparation providing both FSH and LH activity. In men, FSH primarily acts on Sertoli cells and plays an essential role in spermatogenesis, while LH activity stimulates Leydig cells and contributes to endogenous testosterone production. For athletes and bodybuilding practitioners, HMG is particularly relevant in situations involving HPG-axis suppression, especially when supporting testicular function, spermatogenesis, and fertility is a priority.

Product Benefits

• Spermatogenesis Support: FSH activity stimulates Sertoli cells and supports the processes required for sperm production and maturation.
• Testicular Function Support: Maintains gonadotropin stimulation of the testes when endogenous LH and FSH production is insufficient.
• Male Fertility Support: HMG is used in certain protocols intended to restore or stimulate sperm production.
• HPG Axis Support: Can be incorporated into protocols designed to restore gonadal function following hormonal suppression.
• Bodybuilding Context: Particularly relevant following or during periods of use of compounds that suppress endogenous LH and FSH production, when maintaining testicular function and fertility is a priority.

Usage Guidelines

• Reference Protocol: 75 IU per injection, 3 times per week, administered subcutaneously.
• Higher-Dose Protocol: Some specialized protocols use 150 IU, 3 times per week, particularly in cases of insufficient response or severe oligospermia.
• Combination with hCG: In protocols intended to induce or restore male spermatogenesis, HMG is generally combined with hCG to provide sufficient LH stimulation of Leydig cells alongside the FSH activity of HMG.
• Duration: Fertility protocols are generally continued for several months. Restoration of spermatogenesis takes time, and response is typically evaluated through semen analysis.
• Administration: Subcutaneous injection, with injection sites rotated during prolonged use.
• Monitoring: FSH, LH, testosterone, estradiol, and semen parameters may be monitored to assess the individual response.

Precautions and Wellness

• Possible Side Effects: Injection-site reactions, redness, local discomfort, headache, fatigue, fluid retention, or changes in estradiol levels may occur.
• Hormonal Balance: Excessive stimulation may increase estradiol and contribute to symptoms associated with hormonal imbalance.
• Monitoring: During prolonged use, testosterone, estradiol, FSH, and relevant fertility parameters should be monitored.
• Fertility: When fertility restoration is the primary objective, regular semen analysis provides a direct assessment of changes in sperm production.
• Storage: Store the lyophilized product according to the manufacturer's instructions. After reconstitution, refrigerate and protect from light.